期刊文献+

氩氦冷冻消融治疗前后荷瘤鼠程序性死亡配体-1的表达变化 被引量:2

Changes of Expression of Programmed Death Ligand-1(PD-L1) in Tumor-bearing Mice Before and After Argon-Helium Cryoablation
原文传递
导出
摘要 [目的]探讨冷冻治疗对荷瘤鼠单个核细胞表面程序性死亡配体-1(PD-L1)分子表达的影响。[方法]流式细胞术检测冷冻术后2h、3d、7d对照组和冷冻治疗组荷瘤鼠外周血和脾脏单个核细胞表面PD-L1分子的动态表达。[结果]对照组单个核细胞表面PD-L1表达水平逐渐升高(P<0.01),冷冻治疗组逐渐下降(P<0.05);与对照组相比,冷冻治疗术后2h PDL1分子表达有一过性升高,但3d、7d后显著下降(P<0.01)。[结论 ]单个核细胞表面PD-L1分子表达水平随Lewis肺癌进展逐渐增强,冷冻治疗可能可以通过降低PD-L1分子的表达水平,提高抗肿瘤免疫活性。 [Purpose] To investigate the effect of cryoablation on the expression of programmed death ligand-1(PD-L1) on the surface of mononuclear cells of tumor-bearing mice. [Methods] The expression of PD-L1 on the mononuclear cells of peripheral blood and spleen in control group and cryotherapy group was determined by flow cytometry after 2 hours,3 days,7 days of Argon-Helium cryoablation. [Results] The expression level of PD-L1 on the surface of mononuclear cells gradually increased in the control group(P〈0.01),but it gradually decreased in the cryotherapy group(P 0.05).Compared with control group,the expression level of PD-L1 increased after 2 hours of cryoablation,but significantly decreased after 3 days and 7 days(P〈0.05). [Conclusion] The expression level of PD-L1 on the surface of mononuclear cells increases gradually with tumor progression of Lewis lung cancer,and Argon-Helium cryoablation possibly enhances the anti-tumor immune activity by reducing the expression level of PD-L1.
出处 《肿瘤学杂志》 CAS 2015年第7期567-571,共5页 Journal of Chinese Oncology
基金 首都医学发展科研基金(NO.2007-2025)
关键词 冷冻治疗 肺肿瘤 程序性死亡配体-1 cryoablation lung neoplasms programmed death ligand-1(PD-L1)
  • 相关文献

参考文献25

  • 1冯华松,段蕴铀,聂舟山,李泳群,韩志海,张新红,李毅,孟激光,张燕,温居一.氩氦靶向治疗肺部肿瘤725例临床研究[J].中国肿瘤,2007,16(11):906-909. 被引量:22
  • 2李泳群,冯华松,黄友章,段蕴铀.氩氦刀冻融的肺癌细胞联合IL-2刺激人外周血单个核细胞免疫功能[J].生物医学工程研究,2005,24(2):119-120. 被引量:13
  • 3Mu CY,Huang JA,Chen Y,et al. High expression of PD- L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor in- filtrating dendritic ceils maturation [J]. Med Oncol, 2011,28(3) :682-688.
  • 4马薇,罗殿中,陈源,党裔武.PD-L1和PD-1在非小细胞肺癌中的表达及其临床意义[J].实用医学杂志,2011,27(9):1551-1554. 被引量:56
  • 5Chen YB, Mu CY, Huang JA, et al. Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer:a 5-year-follow-up study [J]. Tumori, 2012,98(6) : 751-755.
  • 6Gary R,Voelkl S,Palmisano R,et al. Antigen-specific transfer of functional programmed death ligand 1 from human APCs onto CD8+ T cells via trogocytosis [J]. J Im- munol,2012,188(2) :744-752.
  • 7Gao Q,Wang XY,Qiu SJ,et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and post-operative recurrence in human hepatocellular carci- noma[J]. Clin Cancer Res, 2009,15(3) : 971-979.
  • 8Nakanishi J,Wada Y,Matsnmoto K,et al. Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers[J]. Cancer Immunol Immunother, 2007,56(8) : 1173-1182.
  • 9Shi SJ,Wang LJ,Wang GD,et al. B7-H1 expression is associated with poor prognosis in colorectal carcinoma and regulates the proliferation and invasion of HCTll6 col- orectal cancer cells[J]. PLoS One, 2013,8(10) : 1-11.
  • 10Ghebeh H,Mohammed S,A1-Omair A,et al. The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors[J]. Neoplasia, 2006,8(3) : 190-198.

二级参考文献37

  • 1白春学,张新.肺癌的治疗现状[J].中华结核和呼吸杂志,2006,29(3):146-148. 被引量:61
  • 2[2]Zhang M,Robbins PD,Lotze MT, et al.J Clin Invest,1994,93:1733.
  • 3Carter L,Fouser L A,Jussif J,et al.PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2[J].Eur J Immunol,2002,32(3):634-643.
  • 4Latchman Y,Wood C R,Chernova T,et al.PD-L2 is a second ligand for PD-1 and inhibits T cell activation[J].Nat Immunol,2001,2(3):261-268.
  • 5Dong H,Zhu G,Tamada K,et al.B7-H1,a third member of the B7 family,co-stimulates T-cell proliferation and interleukin-10 secretion[J].Nat Med,1999,5(12):1365-1369.
  • 6Al-Shibli K,Al-Saad S,Donnem T,et al.The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma[J].Histopathology,2009,55(3):301-312.
  • 7Haspot F,Fehr T,Gibbons C,et al.Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway[J].Blood,2008,112(5):2149-2155.
  • 8Konishi J,Yamazaki K,Azuma M,et al.B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression[J].Clin Cancer Res,2004,10(15):5094-5100.
  • 9Wu K,Kryczek I,Chen L,et al.Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions[J].Cancer Res,2009,69(20):8067-8075.
  • 10Jemal A,Siegel R,Xu J,et al. Cancer statistics,2010. CA Cancer J Clin,2010,60:277-300.

共引文献106

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部